Metraipolis › archive › dc_842e1882f338

Chimeric switch and inverted cytokine receptors in T cell therapy: reprogramming T cells to overcome immune suppression in the solid tumor microenvironment — Europe PMC PMID:41132663

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41132663
DOI
10.3389/fimmu.2025.1662238
License (as archived)
solo-consultazione
Archived
2026-11-09T12:38:36.404Z
SHA-256 of the archived text
39f501e304fe62e2727b0b5dcbe38d38370b512ac295bc1a62af6e3bd595000a
Stable URL of this page
https://metraipolis.com/documento/dc_842e1882f338

How to cite

Chimeric switch and inverted cytokine receptors in T cell therapy: reprogramming T cells to overcome immune suppression in the solid tumor microenvironment — Europe PMC PMID:41132663 — Europe PMC (en), https://europepmc.org/article/MED/41132663 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_842e1882f338 (Metraipolis archive dc_842e1882f338, sha256 39f501e304fe62e2727b0b5dcbe38d38370b512ac295bc1a62af6e3bd595000a)
BibTeX
@misc{dc842e1882f338,
  title = {Chimeric switch and inverted cytokine receptors in T cell therapy: reprogramming T cells to overcome immune suppression in the solid tumor microenvironment — Europe PMC PMID:41132663},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41132663},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_842e1882f338; sha256 39f501e304fe62e2727b0b5dcbe38d38370b512ac295bc1a62af6e3bd595000a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41132663. Agents can read the archived copy with the MCP tool read_document.